Arrowhead Research | ARWR - Umlaufvermögen

Aktienkurs
55.05
Täglich Wechseln
0.04 0.07%
Monatlich
-13.57%
Jährlich
258.40%
Q1 Prognose
53.39




Umlaufvermögen Veränderung Datum
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.54B 54M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xencor USD 599.82M 81.38M 2025-12